EnGro Corporation (S44) H2 2023 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2023 earnings summary
28 Oct, 2026Executive summary
FY2023 revenue rose 20.6% YoY to S$160.4m, while net loss widened to S$5.6m from S$0.8m; China market weakness and VC investment fair-value adjustments weighed on results.
ICR demand strengthened in Singapore and Malaysia, while China GGBS selling prices fell sharply; specialty polymer remained profitable despite softer sales.
Proposed FY2023 dividends total 5.0 cents/share, comprising 3.0 cents final and 2.0 cents special, subject to shareholder approval.
Financial highlights
Revenue was S$160.356m versus S$132.985m in FY2022; gross profit was S$41.2m and cost of sales S$119.2m.
Operating activities generated S$1.916m, down from S$8.538m; loss before tax was S$4.220m and net loss S$5.628m.
Net finance costs narrowed to S$1.475m from S$5.506m, including FVTPL losses of S$3.113m versus S$11.588m in FY2022.
Operating cash flow was S$9.629m versus S$5.159m used in FY2022; cash and cash equivalents increased to S$73.478m from S$66.723m.
Outlook and guidance
Singapore construction demand is forecast at S$32bn–S$38bn for 2024; cement sales are expected to remain at FY2023 levels.
Singapore GDP growth is projected at 1.0%–3.0% in 2024; global uncertainty and supply-chain disruption remain downside risks.
China GGBS weakness is expected to persist into at least Q2 2024; priorities include lower costs, stronger products and strategic diversification.
RPT production in Malaysia is planned to cease in Q3 2024 as operations relocate to Indonesia; the relocation is targeted for completion in FY2024.
Latest events from EnGro Corporation
- Revenue rose 6.5%, but profit after tax halved as China and investment income weakened.S44
H1 2023 - Revenue grew 21.3%, but one-off and investment losses cut net profit to $20k.S44
H1 2024 - Construction-led revenue growth restored profitability despite China GGBS pressure and JV impairment.S44
H2 2024 - Revenue growth and fair-value gains lifted H1 profit; operating and market risks persist.S44
H1 2025 - Revenue rose 33.5%; investment gains lifted profit as supply-chain disruptions persisted.S44
H2 2025 - H1 profit surged on an unrealised investment gain as core demand diverged by segment.S44
H1 2026